StocksFin Logo
EW logo
$EW

Edwards Lifesciences Corporation

EW country of incorporation
|
https://www.edwards.com
|
Mr. Michael Mussallem
|
15,700 employees
NYSE | Healthcare | Medical Devices
EW reported its Q422 earnings on December 31, 2022 (97 weeks ago).
$1.35B 1.4% vs. Q421 Revenues Q422
80.87% 5.4% vs. Q421 Gross Profit Margin
29.55% 17.2% vs. Q421 Net Profit Margin
250M -46.9% vs. Q421 Free Cash Flow Q422
$0.65 20.4% vs. Q421 EPS Q422
Company Card Q422
As reported on December 31, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Company Card Q422
As reported on December 31, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022
5.38B
 1.08B
5.38B
$2.46
Q42022
1.35B
+2.2%
257.9M
398.4M
+16%
$0.65
Q32022
1.32B
-4%
253.8M
343.5M
-15.5%
$0.55
Q22022
1.37B
+2.4%
269.4M
406.4M
+8.8%
$0.65
Q12022
1.34B
299.3M
373.6M
$0.6
FY2021
5.23B
 1.25B
1.5B
$2.41
Q42021
1.33B
+1.5%
309.5M
335.3M
-1.4%
$0.54
Q32021
1.31B
-4.8%
311.7M
340.1M
-30.5%
$0.55
Q22021
1.38B
+13.1%
334.3M
489.5M
+44.7%
$0.79
Q12021
1.22B
293.4M
338.2M
$0.54
FY2020
4.39B
 1.08B
823.4M
$1.32
FY2019
4.35B
 1.11B
1.05B
$1.68
FY2018
3.72B
 939.4M
722.2M
$1.15
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022
8.29B
 2.49B
769M
716.8M
5.81B
Q42022
8.29B
 2.49B
769M
691.3M
5.81B
Q32022
8.64B
 2.42B
1.25B
686.8M
6.22B
Q22022
8.43B
 2.48B
1.2B
682.8M
5.94B
Q12022
8.42B
 2.58B
1.03B
688.2M
5.84B
FY2021
8.5B
 2.67B
862.8M
715.8M
5.84B
FY2020
7.24B
 2.66B
1.18B
722.1M
4.57B
FY2019
6.49B
 2.34B
1.18B
645.4M
4.15B
FY2018
5.32B
 2.18B
714.1M
593.8M
3.14B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
309.9M
 -201.5M
-69.9M
-59.9M
250M
+0%
Q32022
309.9M
 -201.5M
-69.9M
-59.9M
250M
-13.5%
Q22022
332.2M
 129.6M
-308.1M
-43.1M
289.1M
+31.1%
Q12022
293.3M
 229.5M
-368.1M
-72.7M
220.6M
FY2021
1.73B
 -1.72B
-356.3M
-329.8M
1.4B
FY2020
1.05B
 -531.1M
-486.9M
-407.3M
647M
FY2019
1.18B
 -595.8M
-115.6M
-278.4M
901M
FY2018
926.8M
 76.7M
-1.1B
-241.7M
685.1M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees